Leonite Fund I, LP 13D and 13G filings for Coeptis Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-11 12:27 pm Purchase | 2024-01-05 | 13G | Coeptis Therapeutics, Inc. COEP | Leonite Fund I, LP | 102,500 6.000% | 102,500 (New Position) | Filing |